News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 31 out 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News 01 nov 2023 Palto Therapeutics receives 150,000 Swiss francs from Venture Kick Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now stands to benefit from 150,0...
News 27 out 2023 UZH researchers develop method for transport of large genes Researchers at the University of Zurich (UZH) have developed a new method for transporting large genes, enabling them to be transferred efficient...
News 23 out 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News 11 out 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
Actualités 29 mar 2022 Le Campus Energypolis a officiellement été inauguré Pleinement opérationnel depuis quelques mois, le Campus Energypolis a officiellement inauguré les bâtiments de la HES-SO Valais-Wallis et de sa H...
Rapport sectoriel 28 out 2022 Opportunités fintech pour sociétés suisses au Pakistan Actuellement, il n’y a qu’un nombre limité de sociétés fintech qui opèrent dans le pays, principalement dans les grandes villes de Lahore, Karach...
News 20 out 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
Guide 18 out 2021 Thailand: Business Opportunities in Digital Health Thailand boasts the second-largest economy in South East Asia, which is expected to advance at a moderate pace in a post-Covid-19 context. With a...
News 19 out 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News 18 out 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
News 18 out 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
最新 29 set 2022 瑞士制药业将可持续发展视为机遇 据一份最新报告显示,可持续发展是瑞士制药业的一个巨大机遇,罗氏和龙沙等公司已在实施各种项目。瑞士提供了良好的整体条件,现在需要一个跨行业的方法。
News 29 set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...